Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-30 Åä 00:27
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 89°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Conference Report]
´ÙÆı۸®Ç÷ÎÁø ¡®½ÅÀå¾à¡¯À¸·Î ÇÕ°ÝÁ¡
THE MOST
2020-10-12 15:58
[Conference Report]
¿¥Æı۸®Ç÷ÎÁø ½ÉºÎÀü Ä¡·áÁ¦·Î º¯½Å ¼º°ø
THE MOST
2020-10-12 15:56
[Sub Story]
½ÉºÎÀü °ü¸®, ¡®±¹³» °¡À̵å¶óÀΡ¯¿¡ µû¸¥ Ä¡·á°¡ Áß¿äÇÏ´Ù
ÀÓ¼¼Çü ±âÀÚ
2020-08-13 16:11
[Cover Story]
Çѱ¹Àο¡°Ô ¸Â´Â ½É³úÇ÷°üÁúȯ ¡®ÆÛÁñ¡¯ ¸ÂÃç°£´Ù
ÀÓ¼¼Çü ±âÀÚ
2020-08-13 16:09
[Sub Story]
[½ÉºÎÀü ȯÀÚÀÇ ´ç´¢º´ °ü¸® Àü·«]
½ÅÀå±â´É¡¤ºÎÀÛ¿ë À§Çè °í·ÁÇÑ Ä¡·á ÇÊ¿ä
THE MOST
2020-08-13 14:48
¶óÀÎ
[Sub Story]
[½ÉºÎÀü ȯÀÚ¿¡¼ Ç×°íÇ÷¾ÐÁ¦ »ç¿ë Àü·«]
¡®½ÉºÎÀü ¾àÁ¦¡¯·Î¼ÀÇ Ç×°íÇ÷¾ÐÁ¦ ÀÎ½Ä ÇÊ¿ä
THE MOST
2020-08-13 14:37
[Sub Story]
1Â÷Ä¡·á ´ëü¿ª·® UP
ÀÌ»óµ· ±âÀÚ
2020-07-26 19:25
[Sub Story]
ADA Guideline Says...
ÀÌ»óµ· ±âÀÚ
2020-07-26 19:12
[Sub Story]
¿¥Æı۸®Ç÷ÎÁø Ä¡·áŸ±ê »ïÇüÁ¦
ÀÌ»óµ· ±âÀÚ
2020-07-26 17:37
[Conference Report]
´ÙÆı۸®Ç÷ÎÁø, ´ç´¢º´ ¡®¿¹¹æ¾à¡¯À¸·Î Æ÷¼®?
THE MOST
2020-07-25 13:22
¶óÀÎ
[Sub Story]
COVID-19 ½Ã´ë ¸¸¼ºÁúȯ °ü¸®Àü·«Àº?
ÀÓ¼¼Çü ±âÀÚ
2020-06-03 13:43
[Sub Story]
¿À¸Þ°¡-3Áö¹æ»ê ȯ°ñÅ»ÅÂ
ÀÌ»óµ· ±âÀÚ
2020-05-14 09:20
[Sub Story]
SGLT-2I¡¤GLP-1RA ASCVD °íÀ§Ç豺±îÁö
ÀÌ»óµ· ±âÀÚ
2020-04-29 15:18
[Conference Report]
SGLT-2 ¾ïÁ¦Á¦, ½ÉºÎÀü¿¡¼ ÀÔÁö ³ÐÈù´Ù
ÀÌ»óµ· ±âÀÚ
2020-01-02 13:53
[Conference Report]
½ÉºÎÀü ÀûÀÀÁõ µµÀü Á¶¸í
ÀÓ¼¼Çü ±âÀÚ
2019-12-03 13:59
¶óÀÎ
[Conference Report]
»çÄíºñÆ®¸±/¹ß»ç¸£Åº ½ÉºÎÀü Ä¡·á Èñ¸Á À̾
THE MOST
2019-12-03 13:55
[Sub Story]
Áß¼ºÁö¹æ Á¶Àý ¶Ç ´Ù¸¥ Àü·«ÀÇ ºÎħ
ÀÌ»óµ· ±âÀÚ
2019-10-08 17:47
[Late Breaking Studies]
¿À¸Þ°¡-3 Áö¹æ»ê ½ÉÇ÷°ü ÇýÅà ±Ù°Å ÃàÀû Áß
ÀÓ¼¼Çü ±âÀÚ
2019-10-08 11:56
[Sub Story]
¡°½ÉºÎÀü¡¤´ç´¢º´ ȯÀÚ¿¡ SGLT-2¾ïÁ¦Á¦¡±
THE MOST
2019-08-08 13:25
[Conference Report]
´ÙÆı۸®Ç÷ÎÁø, ¹ÚÃâ·ü °¨¼Ò HF Ä¡·áÁ¦¿¡ ¡®ÇÑ ¹ß¦¡¯
ÀÓ¼¼Çü ±âÀÚ
2019-04-10 16:32
-
1
2
3
4
5
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top